← Back to Search

Behavioral Intervention

Emotional Resolution Therapy for Anxiety (CalmER Trial)

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be > 18 years of age at Visit
Must have a Generalized Anxiety Disorder (GAD) score of > 5
Must not have
Under the age of 18
Not fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to follow-up 2 (18 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test whether Emotional Resolution (EmRes) therapy can help reduce anxiety in healthcare workers. Researchers believe that EmRes therapy will be more effective in reducing anxiety compared to a control group that

Who is the study for?
This trial is for healthcare workers over 18 who are fluent in English and currently work in a hospital. They should have a Generalized Anxiety Disorder (GAD) score of more than 5, indicating some level of anxiety, and must be able to give written consent to participate.
What is being tested?
The study is testing the effectiveness of Emotional Resolution (EmRes) therapy compared with mindfulness-based gratitude practices in reducing anxiety among healthcare workers.
What are the potential side effects?
Since EmRes and mindfulness are non-invasive therapies focusing on emotional and mental processes, significant physical side effects are not expected. Participants may experience emotional discomfort or increased self-awareness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
My anxiety score is above 5.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I am not fluent in English.
Select...
I am currently taking medication for anxiety.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to follow-up 2 (18 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to follow-up 2 (18 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
EmRes Efficacy - anxiety change at follow-up 1
EmRes Efficacy - anxiety change at follow-up 2
Secondary study objectives
Burnout change at follow-up 1
Burnout change at follow-up 2
Perceived stress change at follow-up 1
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EmResExperimental Treatment1 Intervention
There will be six, one hour, treatment sessions across nine weeks of an Emotional Resolution therapy intervention program, a post treatment assessment, and a follow up assessment three months later. The sessions will occur over zoom with a trained emotional resolution coach.
Group II: MindfulnessActive Control1 Intervention
There will be six, one hour, treatment sessions across nine weeks of a mindfulness intervention program, a post treatment assessment, and a follow up assessment three months later. The sessions will occur over zoom with a trained member of the study staff.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,314,139 Total Patients Enrolled
35 Trials studying Anxiety
38,307 Patients Enrolled for Anxiety
~75 spots leftby Mar 2025